In addition, TIM-3 and LAG-3 were identified as independent biomarkers for the early diagnosis of NSCLC and the combination of TIM-3, LAG-3 and CD137 could increase the diagnostic accuracy (143, 145). Here, HAVCR2 is linked to non-small cell lung carcinoma.